ASLAN Pharma (NASDAQ: ASLN)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-05 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.180 | -0.190 | -0.0100 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ASLAN Pharma (NASDAQ: ASLN) through any online brokerage.
Other companies in ASLAN Pharma’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Celyad Oncology (NASDAQ:CYAD), Larimar Therapeutics (NASDAQ:LRMR), Applied Genetic (NASDAQ:AGTC) and NexImmune (NASDAQ:NEXI).
The latest price target for ASLAN Pharma (NASDAQ: ASLN) was reported by Piper Sandler on Monday, May 23, 2022. The analyst firm set a price target for 3.00 expecting ASLN to rise to within 12 months (a possible 417.51% upside). 2 analyst firms have reported ratings in the last year.
The stock price for ASLAN Pharma (NASDAQ: ASLN) is $0.5797 last updated Today at July 6, 2022, 3:04 PM UTC.
There are no upcoming dividends for ASLAN Pharma.
ASLAN Pharma’s Q2 earnings are confirmed for Friday, August 5, 2022.
There is no upcoming split for ASLAN Pharma.
ASLAN Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.